Cargando…

Antitumor efficacy of the Runx2-dendritic cell vaccine in triple-negative breast cancer in vitro

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis and limited effective treatment. The rise in immunotherapeutic strategies prompted the establishment of a genetic vaccine against TNBC in vitro using a possible biological marker of TNBC. In the present study, d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Mi, Liu, Yu, Zhang, Qiao-Chu, Zhang, Peng, Wu, Jue-Kun, Wang, Jia-Ni, Ruan, Ying, Huang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096217/ https://www.ncbi.nlm.nih.gov/pubmed/30127867 http://dx.doi.org/10.3892/ol.2018.9001

Ejemplares similares

RUNX2: a prognostic biomarker for triple-negative breast cancer?
Publicado: (2014)

Fabrication of Ginsenoside-Based Nanodrugs for Enhanced Antitumor Efficacy on Triple-Negative Breast Cancer
por: Zuo, Shuting, et al.
Publicado: (2022)

Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
por: Han, Joonsu, et al.
Publicado: (2023)

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014)

Glycyrrhiza uralensis water extract enhances dendritic cell maturation and antitumor efficacy of HPV dendritic cell-based vaccine
por: Aipire, Adila, et al.
Publicado: (2017)

Preparation of Triple-Negative Breast Cancer Vaccine through Electrofusion with Day-3 Dendritic Cells
por: Zhang, Peng, et al.
Publicado: (2014)

λ-Carrageenan improves the antitumor effect of dendritic cellbased vaccine
por: Li, Jinyao, et al.
Publicado: (2017)

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
por: Si, Wentao, et al.
Publicado: (2022)

The nature of triple-negative breast cancer classification and antitumoral strategies
por: Kim, Songmi, et al.
Publicado: (2020)

Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines
por: Terashima, Masato, et al.
Publicado: (2014)

A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer
por: Huang, Chen, et al.
Publicado: (2020)

Uric acid enhances the antitumor immunity of dendritic cell-based vaccine
por: Wang, Yihan, et al.
Publicado: (2015)

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Cetuximab and IL-15 Promote NK and Dendritic Cell Activation In Vitro in Triple Negative Breast Cancer
por: Juliá, Estefanía Paula, et al.
Publicado: (2020)

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
por: Miyajima, Noriyuki, et al.
Publicado: (2021)

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
por: Niavarani, Seyedeh-Raheleh, et al.
Publicado: (2023)

Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
por: Benencia, Fabian, et al.
Publicado: (2012)

Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts
por: Liao, Ming-juan, et al.
Publicado: (2014)

Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
por: Mehraj, Umar, et al.
Publicado: (2022)

IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer
por: Li, Peng, et al.
Publicado: (2021)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
por: Owusu-Brackett, Nicci, et al.
Publicado: (2019)

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models
por: Giolito, María V, et al.
Publicado: (2020)

HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel
por: Lyu, Hui, et al.
Publicado: (2023)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
por: Fernández, Natalia B., et al.
Publicado: (2023)

Antitumor Efficacy of α-Solanine against Pancreatic Cancer In Vitro and In Vivo
por: Lv, Chongqing, et al.
Publicado: (2014)

The efficacy of betulinic acid in triple-negative breast cancer
por: Weber, Daniel, et al.
Publicado: (2014)

Deoxypodophyllotoxin Induces a Th1 Response and Enhances the Antitumor Efficacy of a Dendritic Cell-based Vaccine
por: Lee, Jun Sik, et al.
Publicado: (2011)

Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer
por: Jian, Dan, et al.
Publicado: (2022)

Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
por: Llopiz, Diana, et al.
Publicado: (2018)

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
por: Park, Joo Dong, et al.
Publicado: (2022)

Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA
por: Hao, Qiongyu, et al.
Publicado: (2020)

HSulf-1 and palbociclib exert synergistic antitumor effects on RB-positive triple-negative breast cancer
por: Chen, Fengxia, et al.
Publicado: (2020)

Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
por: Xi, Xun, et al.
Publicado: (2022)

Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
por: Tanei, Tomonori, et al.
Publicado: (2016)

Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells
por: Alonso, Eliana Noelia, et al.
Publicado: (2018)

Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells
por: Español, Alejandro, et al.
Publicado: (2022)

Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis enhances antigen cross-presentation and antitumor efficacy through ROS production
por: Zhang, Tingting, et al.
Publicado: (2023)

NIR-guided dendritic nanoplatform for improving antitumor efficacy by combining chemo-phototherapy
por: Ge, Ruifen, et al.
Publicado: (2019)

Antitumor effects and mechanisms of olaparib in combination with carboplatin and BKM120 on human triple-negative breast cancer cells
por: Zhao, Hui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1ujn7akeul3862ltjllptdhej3